Immatics (IMTX) Competitors

MorphoSys (NASDAQ:MOR) and Immatics (NASDAQ:IMTX) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, media sentiment, earnings, institutional ownership, profitability, community ranking, valuation, dividends and risk.

Does the media favor MOR or IMTX?

In the previous week, Immatics had 8 more articles in the media than MorphoSys. MarketBeat recorded 8 mentions for Immatics and 0 mentions for MorphoSys. Immatics' average media sentiment score of 1.28 beat MorphoSys' score of 0.00 indicating that Immatics is being referred to more favorably in the news media.

Company	Overall Sentiment
MorphoSys	Neutral
Immatics	Positive

Which has more volatility and risk, MOR or IMTX?

MorphoSys has a beta of 1.2, suggesting that its stock price is 20% more volatile than the S&P 500. Comparatively, Immatics has a beta of 0.83, suggesting that its stock price is 17% less volatile than the S&P 500.

Is MOR or IMTX more profitable?

Immatics has a net margin of -47.94% compared to MorphoSys' net margin of -226.79%. Immatics' return on equity of -15.90% beat MorphoSys' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
MorphoSys	-226.79%	-694.31%	-22.55%
Immatics	-47.94%	-15.90%	-9.38%

Do analysts recommend MOR or IMTX?

Immatics has a consensus price target of $14.67, suggesting a potential upside of 141.39%. Given Immatics' stronger consensus rating and higher probable upside, analysts plainly believe Immatics is more favorable than MorphoSys.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
MorphoSys	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Immatics	0 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	3.20

Do institutionals & insiders believe in MOR or IMTX?

18.4% of MorphoSys shares are held by institutional investors. Comparatively, 64.4% of Immatics shares are held by institutional investors. 0.1% of MorphoSys shares are held by insiders. Comparatively, 3.3% of Immatics shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Which has higher earnings and valuation, MOR or IMTX?

Immatics has lower revenue, but higher earnings than MorphoSys. Immatics is trading at a lower price-to-earnings ratio than MorphoSys, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
MorphoSys	$238.28M	11.99	-$205.35M	-$3.48	-5.45
Immatics	$144.15M	5.12	-$104.98M	-$0.17	-35.74

Does the MarketBeat Community believe in MOR or IMTX?

Immatics received 7 more outperform votes than MorphoSys when rated by MarketBeat users. Likewise, 74.42% of users gave Immatics an outperform vote while only 38.46% of users gave MorphoSys an outperform vote.

Company	Underperform	Outperform
MorphoSys	Outperform Votes 25 38.46%	Underperform Votes 40 61.54%
Immatics	Outperform Votes 32 74.42%	Underperform Votes 11 25.58%

Summary

Immatics beats MorphoSys on 15 of the 19 factors compared between the two stocks.